lobbying_filings_raw: dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json
dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca Q3 401106114 2359 STRATEGIES 212318 TRAVERE THERAPEUTICS 2024 third_quarter 2024-10-03T18:25:31-04:00 12000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca/", "filing_uuid": "dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2024, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca/print/", "filing_document_content_type": "text/html", "income": "12000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Charles Dujon", "dt_posted": "2024-10-03T18:25:31-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1401 Church St. NW", "registrant_address_2": "#424", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 401106114, "url": "https://lda.senate.gov/api/v1/registrants/401106114/", "house_registrant_id": 45215, "name": "2359 STRATEGIES", "description": "Provide strategic consulting services.", "address_1": "1401 Church St. NW", "address_2": "#424", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "CHARLES DUJON", "contact_telephone": "+1 202-297-7594", "dt_updated": "2025-02-19T14:03:37.162297-05:00"}, "client": {"id": 212318, "url": "https://lda.senate.gov/api/v1/clients/212318/", "client_id": 12, "name": "TRAVERE THERAPEUTICS", "general_description": "Biopharmaceutical company", "client_government_entity": false, "client_self_select": null, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2021-08-19"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Rare kidney disease", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 110845, "prefix": null, "prefix_display": null, "first_name": "CHARLES", "nickname": null, "middle_name": null, "last_name": "DUJON", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Rare kidney disease", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 110845, "prefix": null, "prefix_display": null, "first_name": "CHARLES", "nickname": null, "middle_name": null, "last_name": "DUJON", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, U.S. House of Representatives", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Rare kidney disease", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 110845, "prefix": null, "prefix_display": null, "first_name": "CHARLES", "nickname": null, "middle_name": null, "last_name": "DUJON", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Orphan Drug Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 110845, "prefix": null, "prefix_display": null, "first_name": "CHARLES", "nickname": null, "middle_name": null, "last_name": "DUJON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Orphan drug act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 110845, "prefix": null, "prefix_display": null, "first_name": "CHARLES", "nickname": null, "middle_name": null, "last_name": "DUJON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []}

Links from other tables